LPL Financial’s Astrana Health ASTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10.3M Sell
221,696
-87,429
-28% -$3.15M ﹤0.01% 2121
2026
Q1
$7.58M Hold
309,125
﹤0.01% 2243
2025
Q4
$7.67M Buy
309,125
+131,091
+74% +$3.48M ﹤0.01% 2163
2025
Q3
$5.05M Buy
+178,034
New +$4.82M ﹤0.01% 2452
2022
Q4
Sell
-9,289
Closed -$362K 4581
2022
Q3
$362K Buy
9,289
+101
+1% +$4.62K ﹤0.01% 3423
2022
Q2
$355K Buy
+9,188
New +$349K ﹤0.01% 3487
2021
Q3
Sell
-12,630
Closed -$793K 4433
2021
Q2
$793K Buy
+12,630
New +$467K ﹤0.01% 2762

Other funds holding ASTH

LPL Financial's ASTH Position: Q2 2026 in Review

LPL Financial reduced its Astrana Health (ASTH) stake by 28% in Q2 2026, selling an estimated $3.15M and leaving 221,696 shares worth $10.3M. The position accounts for ﹤0.01% of the portfolio, ranked #2121.

LPL Financial first reported a position in ASTH in Q2 2021 and has held it in 7 quarters since. 210 funds tracked by Wall St. Rank hold ASTH as of Q2 2026.

  • LPL Financial held 221,696 shares of Astrana Health worth $10.3M as of Q2 2026.
  • LPL Financial sold 87,429 Astrana Health shares in Q2 2026, an estimated $3.15M.
  • Astrana Health made up ﹤0.01% of LPL Financial's portfolio in Q2 2026, its #2121 holding.
  • LPL Financial first reported a position in Astrana Health in Q2 2021 and has held it in 7 quarters since.
  • 210 funds tracked by Wall St. Rank held Astrana Health as of Q2 2026.

Based on LPL Financial's 13F filing for Q2 2026, filed 7 Aug 2026.